Omeprazol Bei Sodbrennen Al (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Bei Sodbrennen Al, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is employed to treat acid‑related disorders such as gastro‑oesophageal reflux disease, ulcers and related conditions in adults.

GNH USA supplies Omeprazol Bei Sodbrennen Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and relieves heartburn and regurgitation. - Heartburn: provides rapid symptom relief by decreasing gastric acidity. - Duodenal ulcer: promotes healing by maintaining a less acidic environment. - Gastric ulcer: supports ulcer resolution through sustained acid suppression. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools that may be transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in patients with severe kidney impairment. - Monitor long‑term use: prolonged therapy may increase fracture risk. - Evaluate liver disease: use with caution in hepatic impairment. - Review concomitant medications: potential for interaction with drugs requiring gastric acidity. - Store at ambient temperature: keep in the original pack, protect from moisture.

Omeprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clarithromycin: increased risk of arrhythmia. - Atazanavir: reduced antiviral efficacy. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR. - Digoxin: may increase serum concentrations.